Summary
27 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: 232.4M € against 14.6M €.
What to watch
- Revenue fell by 35% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
- Analysts expect revenue to fall by 11% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedPrice against the Bulios Fair Price
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 9.1% a year over 5 years. Over the last 3 years it fell by 35% a year. For the next fiscal year analysts expect revenue to fall by 11%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of 207.6M €.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 8
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $17 is 129% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.